未找到相关数据
Effect of concomitant medication use on outcomes of ties and placebo arms of the COU-AA-301 and COU-AA-302 studies of abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC).
被引：5
作者：
Hamilton, Robert James
Li, Jinhui
Naini, Vahid
San Kheoh, Thian
De Porre, Peter
Molina, Arturo
Lelbowitz-Amit, Raya
De Bono, Johann Sebastian
Scher, Howard I.
Ryan, Charles J.
Chi, Kim N.
Joshua, Anthony M.
机构：
[1] Univ Toronto, Div Surg Oncol, Princess Margaret Hosp, Toronto, ON, Canada
[2] Janssen Res & Dev, Raritan, NJ USA
[3] Janssen Res & Dev, Los Angeles, CA USA
[4] Janssen Res & Dev, Beerse, Belgium
[5] Janssen Res & Dev, Menlo Pk, CA USA
[6] Univ Toronto, Div Med Oncol, Princess Margaret Hosp, Toronto, ON, Canada
[7] Inst Canc Res, Sutton, Surrey, England
[8] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[9] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[10] Weill Cornell Med Coll, New York, NY USA
[11] Univ Calif San Francisco, San Francisco, CA 94143 USA
[12] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e16045
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16045
引用
收藏
页数：1
相关论文